Led Cancer Screening Innovation in the Global Spotlight
Biotech firm Gene Solutions has received international recognition for its AI-powered multi-cancer screening test, SPOT-MAS 10, following a large-scale study of over 84,000 individuals. The test has been granted FDA Breakthrough Device Designation, signaling a major advancement in Asian-led genomic innovation.
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in